Status: Not yet recruiting
Long-Term Quality Of Life And Symptom Assessment Among Recurrence-Free Patients Who Underwent Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
To evaluate long-term quality of life (QoL) and participant reported symptom burden in disease-free survivors who have undergone cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) at MD Anderson, with primary emphasis on overall (composite) QoL as measured by validated instruments.
Participants needed: 300
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: M.D. Anderson Cancer CenterUpdated: Oct 13, 2026Locations: 1
Eligibility criteria
Males and females; age ≥18 years at the time of enrollment [+6]
1. Evidence of recurrent or active malignancy at time of chart review 2. Underwe...